PE / VC & Portfolio Companies
Big Four pedigree meets compressed execution timelines. We deploy into portfolio companies within 72 hours of engagement start—because your value creation calendar doesn't wait.
Why PE/VC
Traditional consulting firms operate on 18-month timelines. PE firms operate on 100-day value creation windows. We were built for the latter.
PE GPs understand and respect forensic rigor. Our methodology comes from the same high-stakes environment—FCPA investigations, corporate restructurings, regulatory defense—that PE operating partners navigate daily.
One GP relationship generates multiple engagements. We deploy the same Diagnostic and Roadmap methodology across portfolio companies—compressing each successive deployment as institutional familiarity builds.
Every deployment is architected for defensibility at exit. Governance documentation, model explainability frameworks, and audit trails are built in from day one—not retrofitted during due diligence.
Where deal structure permits, we negotiate performance-based equity stakes in lieu of or in addition to advisory fees. Our compensation aligns directly with the GP's return profile—we succeed when you succeed.
Engagement Types
Deployed during diligence. Quantifies the AI value creation opportunity and identifies governance risk before close. Produces a defensible technology assessment that survives LP scrutiny and shapes the post-close playbook.
The highest-leverage window in a PE hold period. We deploy the Roadmap's priority interventions immediately after close—targeting EBITDA expansion before the next board meeting.
12–18 months before exit, we audit the AI deployment for defensibility and build the documentation package that maximizes multiple at sale. AI infrastructure that survives buyer due diligence commands a premium.
Compensation Structure
Where deal structure permits, we negotiate a performance-based equity stake in portfolio companies in lieu of or in addition to advisory fees. This creates asymmetric upside beyond consulting economics and aligns Agentive directly with the GP's return profile.
We succeed when the portfolio company succeeds. That alignment shapes how we prioritize, how aggressively we execute, and how we make vendor recommendations. It is the cleanest possible incentive structure.
Equity structures are subject to legal review and investment adviser registration guidance on a case-by-case basis. We welcome structured conversations with GPs around creative compensation arrangements.
Start The Conversation
We limit annual engagements to ensure every portfolio company receives sustained partner-level attention. If you are evaluating an acquisition or managing a portfolio company with material AI opportunity, we encourage early outreach.